Evidence map›Paper›PMID 39289394›Full record

ArticleScientific reports2024

Integrating neural networks with advanced optimization techniques for accurate kidney disease diagnosis.

Samar Elbedwehy, Esraa Hassan, Abeer Saber, Rady Elmonier

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. GenoDense-Net: unraveling the genomic puzzle of the global pathogen.Tropical diseases, travel medicine and vaccines · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samar ElbedwehyDepartment of Data Science, Faculty of Artificial Intelligence, Kafrelsheikh University, Kafrelsheikh, 33511, Egypt. samarelbedwehy@ai.kfs.edu.eg.
Esraa HassanFaculty of Artificial Intelligence, Kafrelsheikh University, Kafrelsheikh, 33511, Egypt.
Abeer SaberDepartment of Information Technology, Faculty of Computers and Artificial Intelligence, Damietta University, Damietta, 34517, Egypt.
Rady ElmonierDepartment of Internal Medicine, Faculty of Medicine, Al-Azhar University, New Damietta, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney diseases pose a significant global health challenge, requiring precise diagnostic tools to improve patient outcomes. This study addresses this need by investigating three main categories of renal diseases: kidney stones, cysts, and tumors. Utilizing a comprehensive dataset of 12,446 CT whole abdomen and urogram images, this study developed an advanced AI-driven diagnostic system specifically tailored for kidney disease classification. The innovative approach of this study combines the strengths of traditional convolutional neural network architecture (AlexNet) with modern advancements in ConvNeXt architectures. By integrating AlexNet's robust feature extraction capabilities with ConvNeXt's advanced attention mechanisms, the paper achieved an exceptional classification accuracy of 99.85%. A key advancement in this study's methodology lies in the strategic amalgamation of features from both networks. This paper concatenated hierarchical spatial information and incorporated self-attention mechanisms to enhance classification performance. Furthermore, the study introduced a custom optimization technique inspired by the Adam optimizer, which dynamically adjusts the step size based on gradient norms. This tailored optimizer facilitated faster convergence and more effective weight updates, imporving model performance. The model of this study demonstrated outstanding performance across various metrics, with an average precision of 99.89%, recall of 99.95%, and specificity of 99.83%. These results highlight the efficacy of the hybrid architecture and optimization strategy in accurately diagnosing kidney diseases. Additionally, the methodology of this paper emphasizes interpretability and explainability, which are crucial for the clinical deployment of deep learning models.

Indexed as

Kidney DiseasesNeural Networks, ComputerAlgorithmsDeep LearningHumansKidney CalculiTomography, X-Ray ComputedFeature concatenationImage classificationOptimizerVision transformer

Identifiers

PMID39289394
PMCPMC11408592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.